ZA951575B - Use of a tricyclic compound for obtaining medicinal products intended for the treatment of memory/cognitive disorders - Google Patents

Use of a tricyclic compound for obtaining medicinal products intended for the treatment of memory/cognitive disorders

Info

Publication number
ZA951575B
ZA951575B ZA951575A ZA951575A ZA951575B ZA 951575 B ZA951575 B ZA 951575B ZA 951575 A ZA951575 A ZA 951575A ZA 951575 A ZA951575 A ZA 951575A ZA 951575 B ZA951575 B ZA 951575B
Authority
ZA
South Africa
Prior art keywords
memory
treatment
cognitive disorders
medicinal products
tricyclic compound
Prior art date
Application number
ZA951575A
Other languages
English (en)
Inventor
Annie Kamoun
Bruno Delalleau
Antoine Deslandes
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA951575B publication Critical patent/ZA951575B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
ZA951575A 1994-02-25 1995-02-24 Use of a tricyclic compound for obtaining medicinal products intended for the treatment of memory/cognitive disorders ZA951575B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9402160A FR2716623B1 (fr) 1994-02-25 1994-02-25 Utilisation d'un dérivé tricyclique pour l'obtention de médicaments destinés au traitement des troubles mnémo-cognitifs.

Publications (1)

Publication Number Publication Date
ZA951575B true ZA951575B (en) 1995-12-12

Family

ID=9460422

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA951575A ZA951575B (en) 1994-02-25 1995-02-24 Use of a tricyclic compound for obtaining medicinal products intended for the treatment of memory/cognitive disorders

Country Status (10)

Country Link
EP (1) EP0671173A1 (zh)
JP (1) JPH07258089A (zh)
CN (1) CN1051226C (zh)
AU (1) AU684880B2 (zh)
CA (1) CA2143251A1 (zh)
FI (1) FI950725A (zh)
FR (1) FR2716623B1 (zh)
NO (1) NO950714L (zh)
NZ (1) NZ270566A (zh)
ZA (1) ZA951575B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2747921B1 (fr) * 1996-04-24 1998-10-30 Adir Comprime matriciel permettant la liberation prolongee du sel de sodium de tianeptine apres administration par voie orale
FR2791891A1 (fr) * 1999-04-07 2000-10-13 Adir Utilisation de la tianeptine pour l'obtention de medicaments destines au traitement des pathologies de la neurodegenerescence
FR2807039A1 (fr) * 2000-03-31 2001-10-05 Adir NOUVEAU PROCEDE DE PREPARATION DE LA 11-AMINO-3-CHLORO-6,11- DIHYDRO-5,5-DIOXO-6-METHYL-DIBENZO[c,f][1,2]-THIAZEPINE ET APPLICATION A LA SYNTHESE DE LA TIANEPTINE
WO2008109577A1 (en) * 2007-03-05 2008-09-12 Transform Pharmaceuticals, Inc. Polymorphs of 7-[(3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid s,s dioxide and methods of making and using the same
US8198268B2 (en) 2008-10-31 2012-06-12 Janssen Biotech, Inc. Tianeptine sulfate salt forms and methods of making and using the same
WO2010070667A2 (en) * 2008-11-19 2010-06-24 Biophore India Pharmaceuticals Pvt. Ltd. Novel process for the preparation of 7-((3-chloro-6-methyl-5,5-dioxo-6,11-dihydrodibenzo(c,f)(1,2) thiazepin-11-yl)amino)heptanoate
US8355927B2 (en) 2010-11-05 2013-01-15 Genomind, Llc Neuropsychiatric test reports
KR102199871B1 (ko) 2018-12-21 2021-01-08 주식회사 한서켐 3,11-디클로로-6-메틸-6,11-디하이드로디벤조[c,f][1,2]티아제핀 5,5-디옥시드의 제조방법
WO2024206520A1 (en) 2023-03-27 2024-10-03 Tonix Pharmaceuticals Holding Corp. (s)-tianeptine and use in treating disorders and conditions associated with peroxisome proliferator-activated receptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1269551A (en) 1969-03-27 1972-04-06 Science Union & Cie New tricyclic derivatives and process for their manufacture
CH629667A5 (fr) * 1978-03-28 1982-05-14 Science Union & Cie Composition pharmaceutique agissant sur la motricite gastro-intestinale.
FR2635461B1 (fr) * 1988-08-18 1992-01-17 Adir Utilisation de derives tricycliques pour l'obtention de medicaments destines au traitement du stress

Also Published As

Publication number Publication date
EP0671173A1 (fr) 1995-09-13
FI950725A (fi) 1995-08-26
FI950725A0 (fi) 1995-02-17
NO950714D0 (no) 1995-02-24
FR2716623B1 (fr) 1996-08-23
CN1051226C (zh) 2000-04-12
AU1348895A (en) 1995-09-07
FR2716623A1 (fr) 1995-09-01
NZ270566A (en) 1996-01-26
AU684880B2 (en) 1998-01-08
CA2143251A1 (fr) 1995-08-26
JPH07258089A (ja) 1995-10-09
NO950714L (no) 1995-08-28
CN1119100A (zh) 1996-03-27

Similar Documents

Publication Publication Date Title
IL116998A0 (en) Novel indoline compounds processes for their preparation and their use for the treatment of CNS disorders
HK1008180A1 (en) Use of vitamin d 2 or vitamin d 4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
GB2301537B (en) Two-component device for the administration of drugs
HUP9904525A3 (en) Pharmaceutical compositions for the treatment of neurological disorders comprising s-(-)-n-propargyl-1-amino indan
NO306977B1 (no) Anvendelse av tienol[1,5]benzodiazepin for behandling av tilstander i mave/tarmkanalen
GB9421709D0 (en) Therapeutic compounds
CY2249B1 (en) Therapeutic compounds
GB2292079B (en) Coated prednisolone preparation for the treatment of inflamatory bowel disease
ZA951575B (en) Use of a tricyclic compound for obtaining medicinal products intended for the treatment of memory/cognitive disorders
SG45104A1 (en) Process for the preparation of ammoxidation catalysts
IL121329A0 (en) A pharmaceutical composition for the treatment of cancer
GB9419048D0 (en) Treatment of muscular disorders
AU4081393A (en) Medicaments for the treatment of anxiety
ZA932450B (en) Drugs for the treatment of diabetes
GB2272155B (en) Piperazine derivatives for treatment of cognitive disorders
EP0724842A3 (en) Preparation for the treatment of obesity
GB9420080D0 (en) The treatment of liquids
IL107515A0 (en) Diagnosis of mental disorders
ZA945651B (en) Use of benzenesulphonzlindole derivatives for the preparation of medicines
ZA944671B (en) Medicaments for the treatment of inflammatory diseases
EP0692259A3 (en) Use of antibodies specific for HCG for the treatment of cerebral neoplasms
EP0494002A3 (en) Use of certain esters of hexahydro-8-hydroxy-2, 6-methano-2h-quinolizin-3(4h)-one and related compounds for the preparation of medicaments for treating cognitive disorders
KR100248098B1 (en) Pharmaceutical composition for the treatment of dementia
EP0579077A3 (en) 1,3,4-thiadiazinones for the treatment of cardiovascular diseases
GB9401211D0 (en) Formation of pelleted fertiliser products